These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 18984533)
1. Sodium channel blocker tests allow a clear distinction of electrophysiological characteristics and prognosis in patients with a type 2 or 3 Brugada electrocardiogram pattern. Evain S; Briec F; Kyndt F; Schott JJ; Lande G; Albuisson J; Abbey S; Le Marec H; Probst V Heart Rhythm; 2008 Nov; 5(11):1561-4. PubMed ID: 18984533 [TBL] [Abstract][Full Text] [Related]
2. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society]. Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048 [TBL] [Abstract][Full Text] [Related]
3. Low risk for arrhythmic events in asymptomatic patients with drug-induced type 1 ECG. Do patients with drug-induced Brugada type ECG have poor prognosis? (Con). Nishizaki M; Sakurada H; Yamawake N; Ueda-Tatsumoto A; Hiraoka M Circ J; 2010 Nov; 74(11):2464-73. PubMed ID: 20962431 [TBL] [Abstract][Full Text] [Related]
4. Is this a philosophic issue? Do patients with drug-induced Brugada type ECG have poor prognosis? (Pro). Shimizu A Circ J; 2010 Nov; 74(11):2455-63. PubMed ID: 20962432 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome. Ueoka A; Morita H; Watanabe A; Morimoto Y; Kawada S; Tachibana M; Miyamoto M; Nakagawa K; Nishii N; Ito H J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29748178 [TBL] [Abstract][Full Text] [Related]
6. Should all individuals with a nondiagnostic Brugada-electrocardiogram undergo sodium-channel blocker test? Zorzi A; Migliore F; Marras E; Marinelli A; Baritussio A; Allocca G; Leoni L; Perazzolo Marra M; Basso C; Buja G; Thiene G; Iliceto S; Delise P; Corrado D Heart Rhythm; 2012 Jun; 9(6):909-16. PubMed ID: 22334153 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of fever-induced Brugada syndrome. Mizusawa Y; Morita H; Adler A; Havakuk O; Thollet A; Maury P; Wang DW; Hong K; Gandjbakhch E; Sacher F; Hu D; Amin AS; Lahrouchi N; Tan HL; Antzelevitch C; Probst V; Viskin S; Wilde AA Heart Rhythm; 2016 Jul; 13(7):1515-20. PubMed ID: 27033637 [TBL] [Abstract][Full Text] [Related]
18. Asymptomatic Brugada Syndrome: Clinical Characterization and Long-Term Prognosis. Sieira J; Ciconte G; Conte G; Chierchia GB; de Asmundis C; Baltogiannis G; Di Giovanni G; Saitoh Y; Irfan G; Casado-Arroyo R; Julià J; La Meir M; Wellens F; Wauters K; Pappaert G; Brugada P Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1144-50. PubMed ID: 26215662 [TBL] [Abstract][Full Text] [Related]
19. Insights into the location of type I ECG in patients with Brugada syndrome: correlation of ECG and cardiovascular magnetic resonance imaging. Veltmann C; Papavassiliu T; Konrad T; Doesch C; Kuschyk J; Streitner F; Haghi D; Michaely HJ; Schoenberg SO; Borggrefe M; Wolpert C; Schimpf R Heart Rhythm; 2012 Mar; 9(3):414-21. PubMed ID: 22119454 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome. Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]